Drug intelligence / Profile preview

miR-210 precursor

Development stage
Preclinical
Lead developer
Oita University
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intramuscular
01

Overview

miR-210 precursor is a microRNA molecule that serves as the precursor to mature miR-210, a well-characterized hypoxamir induced by hypoxia-inducible factor 1-alpha (HIF1α). In research settings, miR-210 precursors are used to study the biological consequences of miR-210 overexpression, which in clear cell renal cell carcinoma (CCC) has been shown to downregulate E2F transcription factor 3 (E2F3). This downregulation leads to cell cycle disturbances, specifically G2/M phase accumulation, centrosome amplification, and the induction of aneuploidy. While primarily utilized as a laboratory tool for investigating tumorigenesis and chromosome instability, miR-210 and its mimics are also explored for their roles in angiogenesis and metabolic adaptation.

Other names
pre-miR-210pre-miR210pre-miR 210microRNA-210 precursormicroRNA210 precursormicroRNA 210 precursorhsa-mir-210hsa-mir210hsa-mir 210
02

Targets

E2F3 (Transcription factor E2F3)ISCU (Iron-sulfur cluster assembly enzyme ISCU, mitochondrial)RAD52

Beyond the preview

Go deeper on miR-210 precursor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-210 precursor.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call